Advertisement

Sleep

  • CMS releases updated guidance for NIPPV in patients with COPD

    CMS releases updated guidance for NIPPV in patients with COPD

    Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.


  • Study demonstrates strong patient compliance with oral device for OSA

    Study demonstrates strong patient compliance with oral device for OSA

    Evidence suggests that an oral device may be an effective alternative for patients who can’t access or tolerate CPAP therapy.


  • Multidisciplinary panel highlights considerations for GLP-1 agonist use in OSA

    Multidisciplinary panel highlights considerations for GLP-1 agonist use in OSA

    Chitra Lal, MD, FCCP, discussed the current indications and coverage criteria for use of tirzepatide for treatment of OSA, as well as possible roles for other GLP-1 agonists.


  • Clinicians share advice for working with vulnerable patient populations

    Clinicians share advice for working with vulnerable patient populations

    Laura J. Spece, MD, MSc, spoke about specific respiratory health concerns for US military veterans during a session that also focused on optimizing care for patients who are transgender, patients shifting from pediatric to adult care, and patients with limited language proficiency.


  • Specialists review sex-specific variables affecting women with OSA

    Specialists review sex-specific variables affecting women with OSA

    Ashesha Mechineni, MD, explained some of the embedded subtleties in OSA presentation and diagnostic parameters among women.


  • Case-based discussion to troubleshoot PAP nonadherence in OSA

    Case-based discussion to troubleshoot PAP nonadherence in OSA

    Ritwick Agrawal, MD, MS, FCCP, will chair a Wednesday afternoon session addressing high nonadherence in PAP therapy for patients with OSA and exploring innovative neurotherapy options to help optimize care for complex cases.


  • Viloxazine-trazodone combo shows promise for OSA relief

    Viloxazine-trazodone combo shows promise for OSA relief

    Investigator Ludovico Messineo, MD, PhD, said lower dosages will need to be tested to ensure that the beneficial effects on OSA severity are maintained while minimizing side effects.


  • Presenters to share insights into new ventilation reimbursement criteria

    Presenters to share insights into new ventilation reimbursement criteria

    Peter Gay, MD, FCCP, will chair a session about the implications of revised coverage guidelines for noninvasive positive pressure ventilation devices for patients with COPD.


  • CHEST Community Connections: Get to know Chicago health care heroes

    CHEST Community Connections: Get to know Chicago health care heroes

    CHEST is partnering with three Chicago-area organizations—Chicago Asthma Consortium, CommunityHealth, and Mobile Care Chicago—to highlight their critical work in the community and connect them with CHEST 2025 attendees.


  • Using consumer sleep trackers in clinical practice

    Using consumer sleep trackers in clinical practice

    Consumer sleep technologies are offering new ways to monitor sleep. Clinicians need to be prepared to discuss this data, clarify limitations, and interpret findings with patients.